This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don’t share our data with other parties. Read more about our cookie policy

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Read more about our cookie policy

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Cell Biology: Borst, Gerben

silhouette_geen_foto_thumb_man.jpg

Borst, Gerben Group Leader

About Gerben Borst

Co-workers

Slangen, Paul

Paul Slangen

Technician

Experience

In 2016 I started working as a technician in the lab of Gerben Borst, where I  investigate ways to radiosensitize glioma.
Before my career at the Netherlands Cancer Institute, I finished the Master's Program 'Biomolecular Sciences' at VU University in Amsterdam. For my Master's thesis, I studied the radiosensitization of glioma cell lines by inhibition of the MAPK-pathway. This internship was performed at the Neuro-Research group and Radiotherapy department of the VUMc Cancer Center Amsterdam.

Close this window
silhouette_geen_foto_thumb_vrouw.jpg

Mariska van Geldorp

Research technician

Experience

In October 2016 I started as a Research technician in the group of Gerben Borst. On the project we aim to study the irradiation induced tumoral changes to understand how to design targeted strategies killing more radioresistant subpopulations to improve radiotherapy outcome. A better understanding of the dynamics of these irradiation induced changes during treatment is needed to identify when during radiotherapy which of these factor(s) (reoxygenation, repopulation, redistribution, repair) determine the treatment outcome. Subsequently, the therapeutic window can be increased by the use of agents targeting these factors determining the radiotherapy outcome.

Close this window

Contact

  • Office manager

    Mariet van den Berg

  • E-mail

    ma.vd.berg@nki.nl

  • Telephone Number

    +31 20 512 9184

Van den Berg, Mariet
Share this page